The embryonic epicardium is a source of smooth muscle cells and fibroblasts of the coronary vasculature and of the myocardium, but the signalling pathways that control mobilization and differentiation of epicardial cells are only partly known. We aimed to (re-)evaluate the relevance of canonical Wnt-, Hedgehog (Hh)-, Fibroblast growth factor receptor (Fgfr)1/2-, and platelet-derived growth factor receptor alpha (Pdgfra)-signalling in murine epicardial development.
Introduction
The epicardium, the outer epithelial lining of the heart, exerts a crucial role both during development and disease as a source of signals and cells for the underling myocardium and the coronary vasculature. The epicardium arises from extracardiac precursor cells that constitute a grape-like aggregate at the venous pole of the developing heart. Groups of cells detach from this proepicardium, and adhere on the overlying myocardium from around embryonic day (E) 9.5 in the mouse. At E10.5, these cell clusters have spread out and formed a contiguous epithelial monolayer. Concomitant with the ingrowth of the coronary endothelium at E12.5, individual epicardial cells undergo an epithelialmesenchymal transition (EMT) and migrate into the subepicardial space. These epicardium-derived cells (EPDCs) largely differentiate into the interstitial and perivascular fibroblasts and into the smooth muscle cells (SMCs) that surround the coronary vessels. 1 -3 Mobilization and differentiation of epicardial cells is likely to be controlled by a number of autocrine and paracrine signals as suggested by the phenotypic consequences of mice with epicardium-specific (cre/ loxP-mediated) deletion of crucial signalling components. 2, 4 Using cre lines based on GATA binding protein 5 (Gata5)-and Wilms tumor 1 homolog (Wt1)-regulatory elements and a floxed allele of beta-catenin (Ctnnb1), a functional requirement of the canonical (Ctnnb1-dependent) Wnt-signalling pathway in epicardial EMT and coronary SMC differentiation, was suggested. 5, 6 Loss of platelet-derived growth factor receptor alpha (Pdgfra) resulted in reduced EMT and a deficit in cardiac fibroblast formation, 7 which holds true as well for the combined conditional loss of the genes encoding fibroblast growth factor (Fgf) receptors 1/2 which was similarly achieved by a Wt1 cre -mediated recombination of floxed alleles in the epicardium. 8 Furthermore, epicardial derived Fgf-signals have been shown to induce sonic hedgehog (Shh) signalling, which in turn, regulates the formation of arterial and venous coronaries. 9 Finally, we showed by T-box18 (Tbx18) cre -mediated epicardial deletion of the gene encoding the transcription factor Rbpj that Notch-signalling regulates SMC differentiation of EPDCs once they have reached a perivascular position. 10 Shared phenotypic consequences may argue for pathway cooperation in distinct epicardial subprograms including EMT (Wnt/Pdgfra/Fgfr1,2) and SMC differentiation (Wnt/Notch).
However, recent studies indicated that the Gata5::cre line and Wt1-based cre lines, that were used in these conditional gene targeting experiments, 11, 12 may not have mediated specific and/or efficient recombination in the epicardium. 13, 14 Before embarking on genetic interaction studies of Notch-signalling with any of these pathways, we therefore wished to re-evaluate the epicardial requirement of these pathways (canonical Wnt, Fgfr1/Fgfr2, Hh, Pdgfra) using the Tbx18 cre line which we have recently characterized to mediate epicardial recombination. 10 Here, we show that in mice with epicardial (Tbx18 cre -mediated) deletion of Ctnnb1, Fgfr1/2, and of the gene encoding the Shh signal transducer, smoothened (Smo) epicardial mobilization and differentiation is undisturbed. Using genetic gain-of-function approaches, we find evidence that activation of canonical Wnt-and Hh-signalling in the Tbx18 cre lineage is actually deleterious for epicardial and myocardial development in vivo. Furthermore, we confirm that Pdgfra is required for the differentiation of cardiac fibroblasts.
Methods

Mice and genotyping
Medizinische Hochschule Hannover is a holder of a PHS approved animal welfare assurance (A5919-01) in compliance with the guide for the Care 24 were all obtained from the Jackson Laboratory (Bar Harbor, ME, USA). All mice were maintained on an outbred (NMRI) background. NMRI wild-type embryos were used for expression analysis. Embryos for phenotypic analyses were obtained from matings of males triple heterozygous for Tbx18 cre , R26 mTmG and the floxed allele of the pathway mutant, and females homozygous for the same floxed allele of the pathway mutant to be analysed. Timed pregnancies were obtained, by checking vaginal plugs in the morning after mating and noon was designated as embryonic day (E) 0.5. Female mice were sacrificed by cervical dislocation, uteri were harvested in PBS, and embryos decapitated. Tissues were fixed in 4% paraformaldehyde overnight and stored in 100% methanol at 2208C. Genomic DNA prepared from yolk sacs or tail biopsies was used for genotyping by PCR.
Histological analysis
For histological stainings, embryos were fixed as stated earlier, paraffinembedded, and sectioned to 4 mm. Sections were stained with haematoxylin and eosin, following standard procedures.
Immunofluorescence
For immunofluorescence analysis, goat polyclonal antibody anti-Tbx18 ( Immunofluorescence analysis against Ctnnb1 and Tbx18 was performed on cryosections. These were fixed as stated earlier, embedded in tissuefreezing medium (Jung, Germany), and sectioned to 4 mm. All other immunofluorescence analyses were done on 4 mm paraffin sections. All sections were pressure cooked for 3 min in antigen unmasking solution (H-3300, Vector Laboratories Inc.) and signals were amplified using the Tyramide Signal Amplification (TSA) system from Perkin-Elmer (NEL702001KT, Perkin-Elmer LAS). For double staining with GFP, secondary antibody was added during the biotinylated secondary antibody step of the TSA protocol.
In situ hybridization analysis
In situ hybridization analysis on paraffin sections with digoxigenin-labelled antisense riboprobes was performed as described. 25 
Proliferation assay
Cell proliferation was analysed by incorporation of 5-bromo-2-deoxyuridine (BrdU) on 5 mm sections of paraffin-embedded specimens similar to previously published protocols. 26 The quantification of proliferation in was set to one and the normalized data expressed as mean + SD. Capillaries were counted and depicted per cross-section heart area (mm
22
).
Epicardial cell culture
Explant cultures of primary epicardial cells were obtained as described before. 10 For the wound closure assay, the culture medium was supplemented with 10% FBS, and a scratch was made with a P10 tip after 4 days. Imaging Epicardial signalling pathways was performed at 0 and 24 h, and wound closure was determined on bright field images in ImageJ 27 by dividing the scratch area at 0 h at 24 h.
Statistical analysis
Statistical analyses for BrdU incorporation, capillary density, and GFP + cells were performed using the two-tailed Student's t-test. Data were expressed as mean + SD. Differences were considered not significant when the P-value was higher than 0.05, significant (*) when the P-value was below 0.05, highly significant (**) when the P-value was below 0.01, and extremely significant (***) if P , 0.001. For statistics for individual experiments see Supplementary material online, Table 1 .
Image analysis
Sections were photographed using a Leica DM5000 microscope with Leica DFC300FX digital camera. Immunofluorescence of cells, as well as mosaic merge pictures of sections where documented using a Leica DMI6000B microscope with a Leica FC350FX digital camera. The Leica LAS AF 2.3 software was used to generate a mosaic merge of 5 × 5 single pictures, allowing 10% overlap of neighbouring pictures. Whole-mount specimens were photographed on Leica M420 with Fujix digital camera HC-300Z. All images were processed in ImageJ 27 and Adobe Photoshop CS4.
Results
Tbx18 cre allows epicardium-specific recombination of loxP-flanked sequences
The T-box transcription factor gene Tbx18 is strongly expressed in the proepicardium at E9.5 and in the epicardium until E16.5. Other cardiac expression domains include the sinus venosus, and the myocardium of the left ventricle and the interventricular septum. Expression in the latter, however, is weak and scattered. 10 Figure S1 ). However, phenotypic analyses of (Tbx18 cre -mediated) conditionally mutant mice were restricted to the right ventricle throughout this study to account for the endogenous myocardial expression of Tbx18 in the left ventricle but the lack thereof in the right ventricle.
Canonical Wnt-signalling is dispensable for epicardium and EPDC development
To analyse canonical Wnt-signalling in epicardial development, we investigated the expression of Axin2, a bona fide transcriptional target of this pathway, 31 by in situ hybridization on sections of E9.5-E14.5 embryonic hearts (see Supplementary material online, Figure 2) . ;Rosa26 mTmG/+ embryos revealed the absence of Ctnnb1 from the proepicardium and epicardium but not from the myocardium confirming the suitability of the approach to specifically delete Ctnnb1, thus, canonical Wnt-signalling in all epicardial cells (see Supplementary material online, Figure S3 ). Figure S4 ). To further investigate the character of Ctnnb1-deficient epicardial cells, we generated primary epicardial cell cultures from explants of right ventricles of E11.5 hearts. After 4 days in serum-free medium, wildtype cells presented as a monolayer of tightly packed hexagonal cells that showed membrane staining of the epithelial markers Ctnnb1 and tight junction protein 1 (Tjp1, also known as ZO1), nuclear staining of the epicardial marker Wt1, and weak cortical staining of the SM marker actin, alpha 2, smooth muscle, aorta (Acta2). In Ctnnb1-deficient cells, Ctnnb1 was absent but the patterns of Tjp1, Wt1, and Acta2 expression were normal confirming their character as epicardial precursor cells. Irrespective of the genotype, addition of 10% FCS to the medium resulted in the loss of Tjp1 and Wt1, and formation of Acta2-positive stress fibres, consistent with EMT and differentiation into SMCs (see Supplementary material online, Figure S5 ). These results demonstrate that the Tbx18 cre -mediated loss of Ctnnb1 does not affect the formation of the epicardium, EMT or differentiation of EPDCs in vitro and in vivo.
Epicardial expression of a stabilized version of Ctnnb1 leads to the formation of cell clusters
To further clarify the role of Ctnnb1-dependent Wnt-signalling in epicardial development, we used a gain-of-function approach with conditional (Tbx18 oedema. Morphological examination of whole hearts at E11.5 using GFP epifluorescence revealed a reduced overall size, ballooned atria, and clusters of fluorescent cells on the ventricular surface ( Figure 2A ). Histological inspection exposed a severely thinned ventricular myocardium, as well as defined subepicardial cell clusters ( Figure 2B ). Analysis of individual clusters by immunofluorescence for GFP proved the epicardial origin of these clusters, which expressed as expected high levels of Axin2 ( Figure 2C and D) , indicating active Ctnnb1-dependent Wnt-signalling. In situ hybridization analysis of the epicardial marker gene aldehyde dehydrogenase family 1, subfamily A2 (Aldh1a2), and the cardiomyocyte marker troponin I, cardiac 3 (Tnni3), and immunofluorescence for Acta2 showed that these cell clusters were neither epicardial nor myocardial in nature and did not differentiate into SMCs. However, the clusters produced high levels of the extracellular matrix protein fibronectin (Fn)1 that is associated with fibroblast-like cells ( Figure 2E -H ) . The BrdU proliferation assay uncovered a significantly (P ¼ 0.003) elevated proliferation rate at E11.5 both within the epicardial layer (44 + 7%) and the Axin2 + cell clusters (47 + 6%) in the mutant compared with the control heart (22 + 5%) ( Figure 2I , see Supplementary material online, Figure S6 ). Hence, epicardium-specific expression of a stabilized form of Ctnnb1 results in the hyperproliferation of epicardial cells and formation of cellular aggregates of fibroblastlike cells indicating that active canonical Wnt-signalling is deleterious for epicardial development.
Epicardial Hh-signalling is dispensable for epicardial development
To determine the presence of Hh-signalling in the developing epicardium, we investigated the expression of the three ligand genes Shh, Dhh, and Ihh and of patched homolog1 (Ptch1), a well-established transcriptional target and a repressor of Hh-signalling, 32 by in situ hybridization on sections of E9.5-E14.5 embryonic hearts. Expression of Shh, Dhh, Ihh, and Ptch1 was neither detected in the E9.5 proepicardium nor in the epicardium at subsequent stages although other sites of expression were clearly visible (see Supplementary material online, Figure S7 and S8 Figure 3 , see Supplementary material online, Figure S9 ).
Epicardial expression of a constitutive active version of Smo disrupts cardiac development
To investigate the consequences of epicardial activation of Hhsignalling, we (mis-)expressed a constitutively active form of Smo from Figure 1 Epicardial loss of Ctnnb1 does not lead to defects in the coronary vasculature, the ventricular myocardium, or in epicardial derivatives.
Histological analysis by haematoxylin and eosin staining (H&E) and immunofluorescence analysis of IB4, Tagln, Postn, and the cell-lineage marker GFP on mid-transverse sections of E18. Figure 4A and B) . The early coronary plexus formed (shown by IB4 staining), even though the vessels were not located in the deeper compact myocardium. IB4 expression in the endocardium appeared increased possibly due to endocardial thickening ( Figure 4C ). Immunofluorescent detection of the lineage marker GFP and the epicardial marker Wt1 revealed an accumulation of epicardial cells and/or EPDCs and a severe reduction of EMT and of immigration into the myocardium ( Figure 4D -F) . Surprisingly, epicardial proliferation, as detected by the BrdU incorporation assay, was significantly reduced, whereas myocardial proliferation was unaltered at E13.5 ( Figure G and H ) . Thus, Tbx18 cre -mediated expression of a constitutive active form of Smo results in an increase in epicardial cell density, lack of epicardial EMT, and disturbed epicardial-myocardial/endocardial signalling. 
Epicardial Fgfr1/Fgfr2-signalling is not required for heart development
Epicardial Fgfr1/Fgfr2-signalling was recently proposed to induce EPDC migration and fibroblast formation. 8 However, our in situ hybridization analysis did not detect (pro-)epicardial expression of Etv4, a bona fide transcriptional target of the Fgf-signalling pathway, 34 on sections of E9.5-E14.5 embryonic hearts (see Supplementary material online, Figure 10 ). Moreover, embryos with Tbx18 cre -mediated epicardial deletion of Fgfr1 and ;R26 mTmG/+ ) survived embryogenesis and presented histologically normal hearts. In E18.5 hearts, the networks of coronary endothelial cells (IB4) and of fibroblasts (Postn) were neither qualitatively nor quantitatively affected; SMCs (Tagln) of coronary arteries were unaltered. The distribution of the epicardial lineage tracer GFP in the right ventricular myocardium was unchanged both at E14.5 and at E18.5 ( Figure 5 , see Supplementary material online, Figure S11 ). Together, these findings suggest that Fgfr1/ Fgfr2-signalling in the Tbx18 cre lineage is not required for the mobilization and differentiation of epicardial cells.
Epicardial Pdgfra is important for cardiac fibroblast differentiation
Finally, we analysed the role of Pdgfra-signalling 23 Figure 6 ). The GFP + area in the right ventricular myocardium was significantly and highly significantly reduced at E14.5 and E18.5, respectively. Quantification confirmed highly significant reduction of Postn expression, whereas IB4 + cells were unaffected in number at E18.5 (see Supplementary material online, Figure S12 ). To distinguish if the reduction of subepicardial GFP expression reflects a defect in EPDC formation/migration or derives from a subsequent defect in EPDC differentiation, we analysed primary epicardial cell cultures from explants of right ventricles of E11.5 hearts. In FCS-treated explant cultures, a 'wound' in the monolayer was reduced by 50% after 24 h and was completely closed after 72 h, irrespective of the genotype (see Supplementary material online, Figure S13 ) indicating that differentiation but not formation and migration of EPDCs may be primarily affected in Pdgfra-deficient epicardial cells.
Discussion
The embryonic epicardium is a crucial source of cells for the underlying myocardium and the coronary vasculature. Here, we have provided genetic data that suggest that mobilization and differentiation of epicardial cells does not depend on Wnt-, Fgfr1/2-, and Hh/Smo-signalling in the Tbx18 cre lineage but that differentiation of EPDCs into fibroblasts requires the Pdgfra-signalling pathway. Discrepancies between our results and that of earlier reports may rely on the usage of different cre lines, different genetic backgrounds, and/or assay systems ( Table 1) .
Canonical Wnt-signalling is deleterious for epicardial development
Canonical Wnt-signalling has been shown to regulate proliferation and differentiation of progenitor cells in various developmental contexts including myocardial progenitors in the heart. 35 A requirement in epicardial mobilization and differentiation was suggested by two independent studies. First, reduced EMT and a failure of coronary SMC differentiation was reported upon conditional deletion of Ctnnb1 using the transgenic Gata5::cre line. 5 Secondly, Wt1 creERT2 -mediated deletion of Ctnnb1 resulted in a complete absence of epicardial EMT. 6 Our combined analysis on expression (using the faithful read-out by the Wnt-target gene Axin2), and Tbx18 cre -mediated loss-and gain-of-function of Ctnnb1 suggests that this pathway is not involved in epicardial EMT and SMC differentiation but that an epicardial activity may actually be deleterious for cardiac development. These divergent findings may stem from the different cre lines used for conditional targeting of Ctnnb1. In fact, previous work showed that recombination by Gata5::cre is not restricted to epicardial cells but occurs in a widespread fashion in cardiomyocytes, cushion tissue, and endothelial cells, 13 suggesting that epicardial defects may be secondary to changes in these cell types. On the other hand, defects in epicardial EMT as observed with the Wt1 creERT2 line may relate to the variability and incompleteness of epicardial recombination. 14, 6 In contrast, the Tbx18 cre line used in our experiments mediates robust and complete recombination in epicardial cells and seems to be a reliable tool for phenotypic analysis in the right ventricle that lacks any myocardial/endocardial expression of Tbx18. Virally induced epicardial overexpression of a stabilized form of Ctnnb1 was previously reported to lead to increased epicardial EMT. 36 We did not detect epicardial EMT in Tbx18 cre/+ ;Ctnnb1 ex3/+ mice but observed epicardial clustering instead. Lethality around E12.5 prevented to analyse epicardial EMT at later time-points. Both experimental gain-of-function set-ups are very different making a direct comparison difficult. As in the loss-of-function case, independent efforts with additional epicardium-specific cre lines may clarify the findings.
Hh-signalling is deleterious for epicardial development
The Hh-signalling pathway has been shown to be important for vasculogenesis in adult and embryonic development. 37 Claims for a specific role of the pathway in the epicardium and EPDCs were drawn from identification of Shh and Ptch1 expression in the epicardium of whole hearts and from a conditional (Dermo1 cre -mediated) deletion of Smo that resulted in the reduction of coronary artery formation at the early coronary plexus stage. 9, 38, 39 Our investigations on the expression of the Hh-pathway target gene (Ptch1) on cardiac sections revealed no presence in the developing epicardium. Further, our conditional loss-and gain-of-function mutants of the Hh-signalling pathway did not reveal a functional relevance for this pathway in the epicardium but indicated deleterious consequences upon cardiac development once epicardially activated. Since the previously used Dermo1 cre line is additionally active in cushion tissue, 40 these experiments may point to an endothelial/endocardial requirement of Hh-signalling. Furthermore, analysis of embryos at stages of early coronary plexus outgrowth rather that around birth when the coronary system is well established may have detected a defect that may have been transient in nature.
Fgfr1/Fgfr2-signalling in epicardial development
Fgf-signals have been characterized as important paracrine regulators of proliferation, migration, and differentiation of numerous cell types. 41 A crucial function Fgf-signalling in epicardial development in vivo was suggested by a conditional deletion of Fgfr1 and Fgfr2 using the Wt1 cre line. 8 In that study, the authors observed reduced EPDC migration and formation of interstitial fibroblasts. Our analysis of expression of the general Fgf target gene Etv4 does not support the notion that epicardial cells display active Fgf-signalling. Furthermore, combined (Tbx18 cre -mediated) loss of Fgfr1 and Fgfr2 was without phenotypic consequences for epicardial and myocardial development. It is conceivable that haploinsufficiency of Wt1 has interfered with formation and migration of EPDCs and has reduced the sensitivity of Wt1 detection that was used as an EPDC marker in the previous study. 
Epicardial Pdgfra is critical for cardiac fibroblast differentiation
Pdgfs have been characterized as crucial signals in the proliferation of mesenchymal precursor cells, as well as their differentiation and migration. 42 Reports on a functional involvement of Pdgfra-signalling in epicardial development were based on the results from systemic and conditional deletion of Pdgfra using the Wt1 creERT2 line. 7 Our conditional (Tbx18 cre -mediated) deletion experiment confirms that Pdgfra is required for the differentiation of EPDCs in mature cardiac fibroblasts.
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